Form 4: Colgate-Palmolive Director Receives Stock Grant and Options
Statement of Changes in Beneficial Ownership
John P. Bilbrey, a Director at Colgate-Palmolive, received an annual stock grant and stock options on May 11, 2026, as part of the company's incentive compensation plan.
Summary
- Director John P. Bilbrey was granted 2,075 shares of common stock and 2,424 stock options on May 11, 2026.
- The stock grant is part of the company's incentive compensation plan and was credited to a stock unit account.
- The stock options have an exercise price of $86.74 and become exercisable in three equal annual installments starting May 11, 2027.
- Following these transactions, Mr. Bilbrey beneficially owns 39,820 shares of common stock, with 4,719 held indirectly through a trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine compensation adjustments for a director rather than significant financial performance indicators or strategic shifts.
Positives
- Director John P. Bilbrey received a stock grant and stock options, indicating continued alignment with shareholder interests.
- The stock options are part of an incentive compensation plan, designed to reward performance and long-term commitment.
- The stock grant of 2,075 shares and 2,424 options represent a significant award to a key executive.
Future Outlook
Stock options granted to Director John P. Bilbrey become exercisable in installments over three years, with full exercisability by May 11, 2029.
Industry Context
StockSavvy.ai notes that the issuance of stock grants and options to directors is a common practice in the consumer staples industry, aligning executive compensation with company performance and shareholder value.
Stakeholder Impact
- Shareholders: The stock grant and options are part of executive compensation, which can impact dilution but also aligns management incentives with shareholder value.
- Employees: The incentive compensation plan structure may influence overall employee compensation strategies.
- Management: The grants reinforce the compensation structure for directors.
Next Steps
- Director John P. Bilbrey may exercise stock options as they become exercisable over the next three years.
- The stock grant is credited to a stock unit account, with potential future actions dependent on the plan's terms.
Key Dates
| Date | Description |
|---|---|
| 05/11/2026 | Earliest transaction date, date of stock grant and stock option grant. |
| 05/11/2027 | First anniversary of the grant date, when the first installment of stock options becomes exercisable. |
| 05/11/2034 | Expiration date of the stock options. |
| 05/13/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Form 4, SEC Filing, Colgate-Palmolive, Director Compensation, Stock Grant, Stock Options, Beneficial Ownership, Incentive Compensation Plan, CL
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.